Clinical Characteristics of Primary Thyroid Lymphoma in Koreans

被引:45
作者
Hwang, You-Cheol [1 ]
Kim, Tae Yong [3 ]
Kim, Won Bae [3 ]
Shong, Young Kee [3 ]
Yi, Ka Hee [4 ]
Shong, Minho [5 ]
Jo, Young Suk [6 ]
Kim, Won Seog [2 ]
Chung, Jae Hoon [1 ]
机构
[1] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Endocrinol & Metab,Dept Med, Seoul 135710, South Korea
[2] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Hematol Oncol,Dept Med, Seoul 135710, South Korea
[3] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Internal Med, Seoul, South Korea
[4] Korea Canc Ctr Hosp, Dept Internal Med, Seoul, South Korea
[5] Chungnam Natl Univ, Sch Med, Dept Internal Med, Div Endocrinol, Taejon, South Korea
[6] Eulji Univ, Sch Med, Dept Internal Med, Div Endocrinol, Taejon, South Korea
关键词
Primary lymphoma of thyroid; Diffuse large B cell lymphoma; MALT lymphoma; Fine needle aspiration cytology; NON-HODGKINS-LYMPHOMA; NEEDLE ASPIRATION CYTOLOGY; MALIGNANT-LYMPHOMA; PROGNOSTIC-FACTORS; GLAND; CLASSIFICATION; DIAGNOSIS; CANCER;
D O I
10.1507/endocrj.K08E-355
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Primary thyroid lymphoma is a very rare tumor and its prevalence is approximately 0.1% of all thyroid cancers in Korea. Its clinical experience is limited and not familiar to physicians. Therefore, we performed this study to investigate the clinical characteristics of primary thyroid lymphoma in Koreans. We retrospectively analyzed the medical records of the 44 patients with primary thyroid lymphoma from 1991 to 2006 at four major referral hospitals in Korea. Out of 44 patients, eight patients were male and 36 patients were female and their average age was 57 years. Fifty-six percent of patients had underlying Hashimoto's thyroiditis. All but two patients had non-Hodgkin's lymphoma with B cell origin, and eighty percent of patients presented with stage IE or IIE. Twenty-one of 44 patients (48%) had diffuse large B cell lymphoma (DLBCL) and 17 (39%) had MALT lymphoma. Malignancies originating from lymphoid cells were suspected in 10 of eighteen patients with DLBCL (56%) by using fine-needle aspiration cytology (FNAC), and no difference was noted compared with MALT lymphoma (64%). Compared with DLBCL, the patients with MALT lymphoma were more frequently presented with stage I disease (DLBCL vs. MALT lymphoma: 32% vs. 65%, P=0.04). Moreover, in contrast to DLBCL, most of the patients with MALT lymphoma achieved complete response with treatments (DLBCL vs. MALT lymphoma: 53% vs. 94%, P<0.01). Because of the low diagnostic accuracy of FNAC, thyroid biopsy should be considered for the diagnosis of thyroid lymphomas in suspicious cases. The patients with MALT lymphoma were more frequently presented with early stage diseases and this might lead to the favorable Outcome to treatments than those with DLBCL.
引用
收藏
页码:399 / 405
页数:7
相关论文
共 32 条
[1]   PRIMARY MALIGNANT-LYMPHOMA OF THE THYROID - A TUMOR OF MUCOSA-ASSOCIATED LYMPHOID-TISSUE - REVIEW OF 76 CASES [J].
ANSCOMBE, AM ;
WRIGHT, DH .
HISTOPATHOLOGY, 1985, 9 (01) :81-97
[2]  
Ansell SM, 1999, SEMIN ONCOL, V26, P316
[3]  
AOZASA K, 1986, CANCER-AM CANCER SOC, V58, P100, DOI 10.1002/1097-0142(19860701)58:1<100::AID-CNCR2820580118>3.0.CO
[4]  
2-1
[5]   Primary thyroid lymphoma - A retrospective analysis of prognostic factors and treatment outcome for localized intermediate and high grade lymphoma [J].
Belal, AA ;
Allam, A ;
Kandil, A ;
El Husseiny, G ;
Khafaga, Y ;
Al Rajhi, N ;
Ahmed, G ;
Gray, A ;
Ajarim, D ;
Schultz, H ;
Ezzat, A .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2001, 24 (03) :299-305
[6]   Primary thyroid lymphoma: Can the diagnosis be made solely by fine-needle aspiration? [J].
Cha, C ;
Chen, H ;
Westra, WH ;
Udelsman, R .
ANNALS OF SURGICAL ONCOLOGY, 2002, 9 (03) :298-302
[7]  
COMPAGNO J, 1980, AM J CLIN PATHOL, V74, P1
[8]   Malignant lymphoma of the thyroid gland - A clinicopathologic study of 108 cases [J].
Derringer, GA ;
Thompson, LDR ;
Frommelt, RA ;
Bijwaard, KE ;
Heffess, CS ;
Abbondanzo, SL .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2000, 24 (05) :623-639
[9]   Outcome analysis for stage IE and IIE thyroid lymphoma [J].
DiBiase, SJ ;
Grigsby, PW ;
Guo, CF ;
Lin, HS ;
Wasserman, TH .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2004, 27 (02) :178-184
[10]   COMPARISON OF A STANDARD REGIMEN (CHOP) WITH 3 INTENSIVE CHEMOTHERAPY REGIMENS FOR ADVANCED NON-HODGKINS-LYMPHOMA [J].
FISHER, RI ;
GAYNOR, ER ;
DAHLBERG, S ;
OKEN, MM ;
GROGAN, TM ;
MIZE, EM ;
GLICK, JH ;
COLTMAN, CA ;
MILLER, TP .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (14) :1002-1006